Pandial, Florendina .

HRN: 02-96-85  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/19/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/19/2026
05/25/2026
IV
1000
Od
HAP (ESBL E Cloacae) L
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines